Bio Rad Laboratories Inc (BIO) Class A Com Stk USD1

Sell:$353.72Buy:$362.00$4.26 (1.20%)

Prices delayed by at least 15 minutes
Sell:$353.72
Buy:$362.00
Change:$4.26 (1.20%)
Prices delayed by at least 15 minutes
Sell:$353.72
Buy:$362.00
Change:$4.26 (1.20%)
Prices delayed by at least 15 minutes

Company Information

About this company

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Key people

Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Jonathan P. Divincenzo
President, Chief Operating Officer
Roop K. Lakkaraju
Chief Financial Officer, Executive Vice President, Principal Financial officer
Colleen Corey
Executive Vice President Global Human Resources
James J. Barry
Executive Vice President, President - Life Science Group
Michael Crowley
Executive Vice President - Global Commercial Operations
Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Sedat Evran
Executive Vice President - Global Supply Chain
Gregory K. Hinckley
Lead Independent Director
Allison Schwartz
Director
Jeffrey L. Edwards
Independent Director
Melinda Litherland
Independent Director
Arnold A. Pinkston
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Technology
  • Industry
    Scientific & Technical Instr.
  • ISIN
    US0905722072
  • Market cap
    $10.22bn
  • Employees
    8,030
  • Shares in issue
    25.19m
  • Exchange
    New York Stock Exchange
  • Index
    S&P 400 Mid Cap, TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.